[
    [
        {
            "time": "",
            "orginal_text": "这家公司一周超200家机构调研！行业整顿，赛道被“锤”，今年医美还有行情吗？",
            "features": {
                "keywords": [
                    "机构调研",
                    "行业整顿",
                    "医美"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "这家公司一周超200家机构调研！行业整顿，赛道被“锤”，今年医美还有行情吗？",
            "scores": {
                "News_content": "这家公司一周超200家机构调研！行业整顿，赛道被“锤”，今年医美还有行情吗？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "传统药企如何破局创新转型？从Me-too到BIC License-in成首选？",
            "features": {
                "keywords": [
                    "传统药企",
                    "创新转型",
                    "License-in"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "传统药企如何破局创新转型？从Me-too到BIC License-in成首选？",
            "scores": {
                "News_content": "传统药企如何破局创新转型？从Me-too到BIC License-in成首选？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药投向标|中成药将加快集采 晶泰科技完成4亿美元D轮融资 镁信健康完成超20亿元C轮融资",
            "features": {
                "keywords": [
                    "中成药",
                    "集采",
                    "晶泰科技",
                    "融资"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药投向标|中成药将加快集采 晶泰科技完成4亿美元D轮融资 镁信健康完成超20亿元C轮融资",
            "scores": {
                "News_content": "医药投向标|中成药将加快集采 晶泰科技完成4亿美元D轮融资 镁信健康完成超20亿元C轮融资",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]